Gefitinib (Zufinib) Tablet – Treatment for Non-small Cell Lung Cancer
Zufinib 250mg Tablet is a non-small cell lung cancer medication. It is used in individuals whose cancer has progressed to other regions of their bodies, who have faulty epidermal growth factor receptor (EGFR) genes, and who have not previously received cancer therapy.
Non-small cell lung cancer is one of the most common types of lung cancer, affecting both smokers and nonsmokers. Zufinib 250mg Tablet is used to treat non-small cell lung cancer and can be used alone or in conjunction with other medications. It is a strong and very poisonous medication, and you should see your doctor about the dangers and advantages. To keep hydrated, avoid consuming alcohol throughout this therapy and drink lots of water.
Zufinib 250mg Tablet can be taken with or without meals, however, for best effects, take it at the same time every day. You should continue to take it for as long as your doctor recommends. The length of treatment depends on your needs and reaction to treatment. You should take it precisely as prescribed by your doctor. Taking it incorrectly or in excess might result in significant negative effects. It may take many weeks or months for you to notice or feel the advantages, but do not stop taking it until your doctor instructs you to do so.
USES OF GEFITINIB (ZUFINIB) 250MG TABLET
- Non-small cell lung cancer
WORKS OF GEFITINIB (ZUFINIB) 250MG TABLET
Zufinib 250mg Tablet is a cancer-fighting drug. It works by preventing the aberrant protein from signaling cancer cells to proliferate. This aids in the prevention or slowing of the spread of cancer cells.
DIRECTIONS FOR USE:
Take this medication at the dose and for the period prescribed by your doctor. Take it all at once. It should not be chewed, crushed, or broken. Zufinib 250mg Tablet can be taken with or without meals, although it is best to take it at the same time every day.
SIDE EFFECTS OF GEFITINIB (ZUFINIB) 250MG TABLET
- Dry skin
- Loss of appetite
- Stomatitis (Inflammation of the mouth)
- Weight loss
WARNING & PRECAUTIONS
Zufinib 250mg tablet may induce adverse effects that impair your ability to drive.
Zufinib 250mg Tablet may cause drowsiness. This might impair your driving skills.
In individuals with severe renal disease, Zufinib 250mg Tablet should be taken with care. Zufinib 250mg Tablet dosage may need to be adjusted. Please visit your physician.
In people with liver problems, Zufinib 250mg Tablet is probably safe to use. Based on the current data, it appears that no dosage change of Zufinib 250mg Tablet is required in these individuals. Please visit your physician.
Zufinib 250mg Tablet should not be used during pregnancy since there is clear evidence of danger to the developing infant. However, if the advantages outweigh the hazards, the doctor may seldom prescribe it in life-threatening conditions. Please visit your physician.
Zufinib 250mg Tablet is most likely dangerous to take when nursing. According to limited human research, the medication may transfer into breastmilk and damage the infant.
Fedelty Health Care is a Gefitinib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.